TANAKAN

This brand name is authorized in Brazil, France, Hong Kong SAR China, Lithuania, Poland, Romania, Tunisia.

Active ingredients

The drug TANAKAN contains one active pharmaceutical ingredient (API):

1	Ginkgo biloba UNII Y5967KO1JH - GINKGO BILOBA LEAF OIL
	The exact mechanism of action of ginkgo biloba is not known. Human pharmacological data show increased EEG vigilance in geriatric subjects, reduction in blood viscosity and improved cerebral perfusion in specific areas in healthy men (60-70 years) and reduction in platelet aggregation. Additionally, vasodilating effects on forearm blood vessels causing increased regional blood flow are shown.
	Read more about Ginkgo biloba

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N06DX02	Ginkgo folium	N Nervous system → N06 Psychoanaleptics → N06D Anti-dementia drugs → N06DX Other anti-dementia drugs
Discover more medicines within N06DX02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	500220050045207, 500220050045307, 500220050045407, 500220050045507
FR	Base de données publique des médicaments	60287373, 66029390
HK	Department of Health Drug Office	54598
LT	Valstybinė vaistų kontrolės tarnyba	1011610, 1011611, 1011612, 1038557, 1073003, 1090991
PL	Rejestru Produktów Leczniczych	100065516, 100161728, 100252490, 100263305, 100356024, 100423499
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W66209002, W66209003, W66209004, W66209005, W66210001, W66210002, W66210003, W66210004
TN	Direction de la Pharmacie et du Médicament	9143011, 9143012, 9253501